Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.

Area of Science:

• Hematology
• Cancer Biology
• Molecular Oncology

Background:

• Acute leukemias are often associated with unfavorable patient survival and lineage plasticity.
• Current models suggest leukemias originate from hematopoietic stem cells with stable differentiation potential.
• However, the origin of plasticity in certain leukemia cases remains incompletely understood.

Purpose of the Study:

• To investigate the role of progenitor cell differentiation states in driving leukemia lineage plasticity.
• To explore the potential of T-lymphoid progenitors as a source for myeloid leukemogenesis.
• To identify novel therapeutic strategies targeting thymus-derived myeloid leukemia.

Main Methods:

• Utilized a mouse model with enhanced c-Myc expression to study leukemia development at the single-cell level.
• Analyzed gene expression and epigenetic memory in T-cell-derived myeloid blasts.
• Correlated findings with human leukemia cohorts and investigated signaling pathway involvement.

Main Results:

• Demonstrated that T-lymphoid progenitors can retain broad malignant potential, differentiating into myeloid leukemia.
• Identified that these T-cell-derived myeloid blasts maintain T-cell transcription factors, creating an epigenetic memory.
• Discovered that targeting Jak2/Stat3 signaling presents a potential therapeutic avenue for this leukemia subtype.

Conclusions:

• Suggests the thymus as a potential source for myeloid leukemia, driven by leukemic plasticity.
• Proposes a model where dynamic progenitor differentiation states contribute to unique neoplastic identities.
• Highlights pathway-directed therapy against thymus-derived myeloid leukemogenesis as a promising option.